The DTI in the UK sent a Global Watch Mission team to California last year to look at biosensors and biosensing "major global industries, with the worldwide total annual sales of medical biosensors exceeding £2.8 billion in 2003". The team has just reported back.
A Chicago merchant bank will take a new twist on selling intellectual property next week when it holds a live auction to sell 400-plus patents from some of the most valued technology innovators in the world. Lori Valigra looks at the list.
Endorsed - if lukewarmly - by Europe's leaders, the plan for a "European Institute of Technology", now goes to the back rooms in Brussels for more cooking.
The Scottish Funding Council has put up £870,000 in an initiative to provide a single point of access for matching the know-how within the country's 20 universities and research institutions with the needs of small- and medium-sized enterprises.
The UK budget last week set out measures to extract more value, improve quality and increase innovation from the billions the government spends on science. Nuala Moran looks into the small print.
A Linköpings Tekniska Högskola spin-out has developed plug-in devices for the direct production of 3D animations. The company is now looking for a first private funding round.
A small UK charity has turned entrepreneur to develop a low cost, mass manufactured, modern device to pump the blood of people whose heart muscle is failing.
Sweden is ranked number one among 31 European nations for its spending on R&D - but it is still looking for its first home-grown biotechnology product.
An Israeli academic has developed a virtual reality device to help people with neurodegenerative diseases to improve their walking. He is now seeking funding of about $500,000 to commercialise it and looking for manufacturing partner.
Philippe Pouletty is on a roll. One by one, the serial entrepreneur with a penchant for provocative lobbying is seeing his ideas become official French policy. But not everyone is pleased.
A new wave of companies with rich backers plans to change how people interact over the Internet. But sceptics are still searching for a sustainable business model.
For 30 years, the European Commission has been trying to fix the broken patent process, but keeps running afoul of entrenched intestests. Is it any wonder that European countries keep dropping in the world patent leagues?
Acrongenomics Inc., a Swiss life science venture company and Molecular Vision Ltd., a spin-out from the Imperial College London, said they have signed a memorandum of understanding to jointly develop diagnostic devices for diabetes, drug abuse, STDs and cardiovascular diseases.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.